Clinical Trial Update: A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

View source ↗

Summary

A post-marketing surveillance study to assess the safety of luspatercept in Korean patients with myelodysplastic syndrome or beta-thalassemia. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndrome

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Myelodysplastic Syndrome, Beta Thalassemia | Status: RECRUITING